An Integrated VQ-VAE Approach for Limited Sample Retinal Vessel Segmentation and Multidisease Diagnosis

• by Haojun Yu, Zongcai Tan, Huazhen Liu, Xinyu Xu

• March 1, 2026

Do Systemic Alpha-2 Agonists Lower Glaucoma Risk?

A large US cohort study found systemic alpha-2 agonist use was associated with a lower hazard of glaucoma-related diagnoses vs. beta-blockers.

• by Andrea Surnit

• July 8, 2026

• 3 min

Phacoemulsification with goniosynechialysis for nanophthalmos with secondary angle-closure or secondary angle-closure glaucoma: a 20-case series and stepwise management strategy

• by Hongyan Zhu, Zuohong Wu, Yong Wang, Xun Zhan, Jin Lv, Li Ye

• June 1, 2026

Outcomes of Selective Laser Trabeculoplasty as Initial Treatment for Glaucoma: A Retrospective Analysis from Enugu, Nigeria

• by Nkiru Nwamaka Kizor-Akaraiwe, Suhanyah Okeke, Chukwu Oko, Nkechi Uche, Obinna Jude Shiweobi

• February 14, 2026